FilingReader Intelligence

Aurobindo Pharma subsidiary experiences fire, production temporarily paused

April 28, 2025 at 07:12 PM UTCBy FilingReader AI

Aurobindo Pharma (BSE:AUROPHARMA) announced a fire incident at its wholly-owned step-down subsidiary, Lyfius Pharma Private Limited, on April 27, 2025. The fire, which occurred in the vicinity of the coal crusher area at the Penicillin-G manufacturing facility in Kakinada SEZ, Andhra Pradesh, damaged some ancillary equipment. Aurobindo Pharma stated that core manufacturing infrastructure was not impacted and no injuries were reported. Production at the Lyfius Pharma plant will be temporarily suspended for an estimated 20 to 25 days to facilitate equipment replacements. The company clarified that the facility is fully insured and the incident is not expected to have a material impact on the group’s operations or financials. An assessment of the damage is currently underway to ascertain the exact reasons for the fire and the quantum of loss, which is covered by insurance.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

BSE:AUROPHARMABombay Stock Exchange

News Alerts

Get instant email alerts when Aurobindo Pharma publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →